Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

References for PMC Articles for PubMed (Select 19088123)

1.

Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models.

Shenkar R, Venkatasubramanian PN, Wyrwicz AM, Zhao JC, Shi C, Akers A, Marchuk DA, Awad IA.

Neurosurgery. 2008 Oct;63(4):790-7; discussion 797-8. doi: 10.1227/01.NEU.0000315862.24920.49.

2.

ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish.

Hogan BM, Bussmann J, Wolburg H, Schulte-Merker S.

Hum Mol Genet. 2008 Aug 15;17(16):2424-32. doi: 10.1093/hmg/ddn142. Epub 2008 May 10.

3.

Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts.

Liquori CL, Penco S, Gault J, Leedom TP, Tassi L, Esposito T, Awad IA, Frati L, Johnson EW, Squitieri F, Marchuk DA, Gianfrancesco F.

Neurogenetics. 2008 Feb;9(1):25-31. Epub 2007 Dec 1.

PMID:
18060436
4.

KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions.

Glading A, Han J, Stockton RA, Ginsberg MH.

J Cell Biol. 2007 Oct 22;179(2):247-54.

5.

Proteomic identification of the cerebral cavernous malformation signaling complex.

Hilder TL, Malone MH, Bencharit S, Colicelli J, Haystead TA, Johnson GL, Wu CC.

J Proteome Res. 2007 Nov;6(11):4343-55. Epub 2007 Sep 27.

PMID:
17900104
6.

CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.

Voss K, Stahl S, Schleider E, Ullrich S, Nickel J, Mueller TD, Felbor U.

Neurogenetics. 2007 Nov;8(4):249-56. Epub 2007 Jul 27.

PMID:
17657516
7.
8.

Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations.

Zhang J, Rigamonti D, Dietz HC, Clatterbuck RE.

Neurosurgery. 2007 Feb;60(2):353-9; discussion 359.

PMID:
17290187
9.

Deletions in CCM2 are a common cause of cerebral cavernous malformations.

Liquori CL, Berg MJ, Squitieri F, Leedom TP, Ptacek L, Johnson EW, Marchuk DA.

Am J Hum Genet. 2007 Jan;80(1):69-75. Epub 2006 Nov 14.

10.

santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish.

Mably JD, Chuang LP, Serluca FC, Mohideen MA, Chen JN, Fishman MC.

Development. 2006 Aug;133(16):3139-46.

11.

Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations.

Plummer NW, Squire TL, Srinivasan S, Huang E, Zawistowski JS, Matsunami H, Hale LP, Marchuk DA.

Mamm Genome. 2006 Feb;17(2):119-28. Epub 2006 Feb 7.

PMID:
16465592
12.

Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development.

Petit N, Blécon A, Denier C, Tournier-Lasserve E.

Gene Expr Patterns. 2006 Jun;6(5):495-503. Epub 2006 Feb 7.

PMID:
16455310
13.

CCM2 expression parallels that of CCM1.

Seker A, Pricola KL, Guclu B, Ozturk AK, Louvi A, Gunel M.

Stroke. 2006 Feb;37(2):518-23. Epub 2005 Dec 22.

14.

Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.

Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, Cannella M, Maglione V, Ptacek L, Johnson EW, Marchuk DA.

Hum Mutat. 2006 Jan;27(1):118.

PMID:
16329096
15.

CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.

Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, Marchuk DA.

Hum Mol Genet. 2005 Sep 1;14(17):2521-31. Epub 2005 Jul 21.

16.

Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion.

Gault J, Shenkar R, Recksiek P, Awad IA.

Stroke. 2005 Apr;36(4):872-4. Epub 2005 Feb 17.

17.

Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations.

Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, Jacquet G, Lonjon M, Moreau JJ, Neau JP, Parker F, Tremoulet M, Tournier-Lasserve E; Société Française de Neurochirurgie.

Am J Hum Genet. 2005 Jan;76(1):42-51. Epub 2004 Nov 12.

18.

Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations.

Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, Marchuk DA.

Am J Pathol. 2004 Nov;165(5):1509-18.

19.

Somatic mutations--not just for cancer anymore.

Puck JM, Straus SE.

N Engl J Med. 2004 Sep 30;351(14):1388-90. No abstract available.

PMID:
15459299
20.

Search for loss of heterozygosity and mutation analysis of KRIT1 gene in CCM patients.

Marini V, Ferrera L, Pigatto F, Origone P, Garrè C, Dorcaratto A, Viale G, Alberti F, Mareni C.

Am J Med Genet A. 2004 Sep 15;130A(1):98-101. No abstract available.

PMID:
15368504
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk